The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist
- Bioorg Med Chem Lett. 2001 Feb 12;11(3):319-21. doi: 10.1016/s0960-894x(00)00670-3.
Affiliations
- 1. AstraZeneca, Three Biotech, Worcester, MA 01605, USA. [email protected]
PMID: 11212100
DOI: 10.1016/s0960-894x(00)00670-3
Abstract
The 5-HT3 receptor antagonist tropisetron (ICS 205-930) was found to be a potent and selective partial agonist at alpha7 nicotinic receptors. Two Other 5-HT3 receptor antagonists, ondansetron and LY-278,584, were found to lack high affinity at the alpha7 nicotinic receptor. Quinuclidine analogues (1 and 2) of tropisetron were also found to be potent and selective partial agonists at alpha7 nicotinic receptors.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: 5-HT Receptor; nAChR; p38 MAPK; NF-κB; AP-1; Nuclear Factor of activated T Cells (NFAT); JAK
-